PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 5, 2025Dermatology and Therapy3 citationsOpen Access

Real-World Effectiveness and Safety of Tildrakizumab in Moderate-to-Severe Psoriasis: A Multicenter Experience in the Basque Country

View Full Paper
RIR. IzuIGIsabel Gainza-ApraizMMMikel Meruelo-Ruano

Key Points

  • High effectiveness was noted in improving psoriasis symptoms and safety assessments.
  • In a multicenter cohort, patients showed significant improvements in plaque psoriasis with tildrakizumab administration.
  • The observational analysis across several centers provided real-world evidence of its therapeutic potential.
  • These findings may enable better treatment strategies for patients with moderate-to-severe psoriasis.

Abstract

Tildrakizumab demonstrated high effectiveness and a favorable safety profile in this large, real-world multicenter cohort. These findings support its role as a reliable therapeutic option for patients with moderate-to-severe plaque psoriasis in clinical practice.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Izu et al. (2025) studied this question.

synapsesocial.com/papers/694022532d562116f28fc490https://doi.org/10.1007/s13555-025-01607-8
Ask AI
Helpful
Bookmark
Share
View Full Paper